Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04186260 · ClinicalTrials.gov registry record · NA
A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04186260 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 15 participants.
The verdict
NCT04186260, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Using a small Randomized Controlled Trial (RCT) study design, PNPLA3 risk allele carriers (CG/GG genotype) with NAFLD, will be assigned 2:1 to a tailored NAFLD-specific weight loss intervention compared to a wait-list control group.
Interventions
- OTHER Wait-list control
- BEHAVIORAL NAFLD-specific weight loss intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2025-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04186260
The ClinicalTrials.gov registry entry for NCT04186260 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Wait-list control is the first listed.
NCT04186260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04186260 about?
NCT04186260 is a clinical study titled "A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men". Using a small Randomized Controlled Trial (RCT) study design, PNPLA3 risk allele carriers (CG/GG genotype) with NAFLD, will be assigned 2:1 to a tailored NAFLD-specific weight loss intervention compared to a wait-list control group.
What is the current status of trial NCT04186260?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2024-02-05. Estimated completion is 2025-05-30.
What interventions are being tested in trial NCT04186260?
The interventions under investigation include: Wait-list control (OTHER), NAFLD-specific weight loss intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04186260?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.